Dr. Agarwal's unit invests USD 2,00,000 in Ethiopia arm
Orbit Healthcare Services (Mauritius) Limited, a wholly owned subsidiary of Dr. Agarwal's Health Care Limited, invested USD 2,00,000 in Orbit Health Care ETH PLC. The investment, completed on May 26, 2026, makes the Ethiopian entity a step-down wholly owned subsidiary.

*this image is generated using AI for illustrative purposes only.
Orbit Healthcare Services (Mauritius) Limited, a wholly owned subsidiary of dr. agarwal's health care , has completed an investment of USD 2,00,000 in Orbit Health Care ETH PLC. The investment was made towards the subscription of shares in the newly incorporated entity, as per prevailing currency rates. This strategic move expands the company's footprint into Ethiopia through its Mauritius-based subsidiary.
With this transaction, Orbit Health Care ETH PLC has become a wholly owned subsidiary of Orbit Healthcare Services (Mauritius) Limited. Consequently, the Ethiopian entity is now classified as an indirect and step-down wholly owned subsidiary of Dr. Agarwal's Health Care Limited. The intimation regarding the completion of this investment was received by the company on May 26, 2026.
Investment Structure
The investment follows the company's earlier communication dated February 03, 2026, regarding the proposed incorporation of a subsidiary in Ethiopia. The financial structure of the transaction is outlined below:
| Entity | Investment Status | Relationship |
|---|---|---|
| Orbit Healthcare Services (Mauritius) Limited | Investor | Wholly owned subsidiary of Dr. Agarwal's Health Care Limited |
| Orbit Health Care ETH PLC | Investee | Wholly owned subsidiary of Orbit Healthcare Services (Mauritius) Limited |
The disclosure was made to the exchanges in compliance with Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Historical Stock Returns for Dr. Agarwal's Health Care
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.10% | -2.72% | -2.40% | -11.79% | +14.12% | +9.37% |
What is the projected timeline for the Ethiopian subsidiary to commence commercial operations?
How does Dr. Agarwal's plan to fund the operational setup and initial capital expenditure in Ethiopia?
What specific ophthalmic services will be prioritized in the Ethiopian market given the local healthcare needs?


































